Vigo, D., Thornicroft, G. & Atun, R. Estimating the true international burden of psychological sickness. Lancet Psychiatry 3, 171–178 (2016).
World Well being Group Regional Workplace for Europe. WHO European Framework for Motion on Psychological Well being 2021–2025. https://www.who.int/europe/health-topics/mental-health#tab=tab_1 (2022).
Robert Koch-Institut. Gesundheit in Deutschland. Gesundheitsberichterstattung des Bundes. https://www.destatis.de/DE/Themen/Gesellschaft- (2015).
Bundesministerium für Bildung und Forschung. Melancholy: Schatten auf der Seele. https://www.gesundheitsforschung-bmbf.de/de/depression-schatten-auf-der-seele-5949.php (2023).
Porst, M. et al. The burden of illness in Germany on the nationwide and regional degree. Dtsch Arztebl Int 119, 785–792 (2022).
Rabe-Menssen, C., Hübner, L. & Maaß, E. Report Psychotherapie 2023. Sonderausgabe psychische Gesundheit in der COVID-19-Pandemie. https://www.dptv.de/im-fokus/wissenschaft-und-forschung/report-psychotherapie/ (2023).
DAK Gesundheit. Psychreport 2023. Entwicklungen der psychischen Erankungen im Job: 2012-2022. https://www.dak.de/dak/unternehmen/reporte-forschung/psychreport-2023_32618#rtf-anchor-downloads-psychreport-2023-ergebnis-prasentation (2023).
Grobe, T. G., Braun, A. & Starke, P. BARMER Gesundheitsreport 2023. Risikofaktoren für psychische Erkrankungen, Schriftenreihe zur Gesundheitsanalyse – Band 41. https://www.bifg.de/publikationen/reporte/gesundheitsreport-2023 (2023).
Barak, A., Hen, L., Boniel-Nissim, M. & Shapira, N. A complete overview and a meta-analysis of the effectiveness of internet-based psychotherapeutic interventions. J. Technol. Hum. Serv. 26, 109–160 (2008).
Karyotaki, E. et al. Do guided internet-based interventions end in clinically related adjustments for sufferers with despair? A person participant information meta-analysis. Clin. Psychol. Rev. 63, 80–92 (2018).
Klein, J. P. et al. Results of a psychological web intervention within the therapy of gentle to average depressive signs: Outcomes of the EVIDENT examine, a randomized managed trial. Psychother. Psychosom. 85, 218–228 (2016).
Amelung, V., Nüsken, J. & Ledeganck, M. BMC-Innovationspanel. https://www.bmc.com/company/bmc-innovation-labs.html (2021).
Brönneke, J. B., Hagen, J., Kircher, P. & Matthies, H. Digitalisierte Gesundheitsversorgung im Jahr 2030 – ein mögliches Szenario. Bundesgesundheitsblatt Gesundheitsforsch. Gesundheitsschutz 64, 1285–1291 (2021).
Uncovska, M., Freitag, B., Meister, S. & Fehring, L. Affected person acceptance of prescribed and totally reimbursed mHealth apps in Germany: An UTAUT2-based on-line survey examine. J. Med. Syst. 47, 14 (2023).
Firth, J. et al. Can smartphone psychological well being interventions cut back signs of hysteria? A meta-analysis of randomized managed trials. J. Have an effect on Disord. 218, 15–22 (2017).
Lingg, M. & Lütschg, V. Well being system stakeholders’ perspective on the position of cellular well being and its adoption within the swiss well being system: Qualitative examine. JMIR Mhealth Uhealth 8, e17315 (2020).
Hemkens, L. G. Nutzenbewertung digitaler Gesundheitsanwendungen – Herausforderungen und Möglichkeiten. Bundesgesundheitsblatt Gesundheitsforsch. Gesundheitsschutz 64, 1269–1277 (2021).
Dahlhausen, F. et al. There’s an app for that, however no person’s utilizing it: Insights on bettering affected person entry and adherence to digital therapeutics in Germany. Digit Well being 8, 20552076221104672 (2022).
Morton, Ok. et al. Utilizing digital interventions for self-management of persistent bodily well being circumstances: A meta-ethnography overview of printed research. Affected person Educ. Couns. 100, 616–635 (2017).
Dahlhausen, F. et al. Physicians’ attitudes towards prescribable mHealth apps and implications for adoption in Germany: Blended strategies examine. JMIR Mhealth Uhealth 9, e33012 (2021).
Uncovska, M., Freitag, B., Meister, S. & Fehring, L. Ranking evaluation and BERTopic modeling of shopper versus regulated mHealth app critiques in Germany. NPJ Digit Med. 6, 115 (2023).
Schmidt, L., Pawlitzki, M., Renard, B. Y., Meuth, S. G. & Masanneck, L. The three-year evolution of Germany’s digital therapeutics reimbursement program and its path ahead. NPJ Digit Med. 7, 139 (2024).
Bundesinstitut für Arzneimittel und Medizinprodukte. DiGA-Verzeichnis. https://diga.bfarm.de/de/verzeichnis?sort=%5Bpercent5D (2024).
Krämer, R., Köhne-Volland, L., Schumacher, A. & Köhler, S. Efficacy of a web-based intervention for depressive problems: Three-arm randomized managed trial evaluating guided and unguided self-help with waitlist management. JMIR Kind. Res. 6, e34330 (2022).
Haaf, R., Machleid, F. & Köhler, S. Überblick über digitale Gesundheitsanwendungen mit Fokus Melancholy. Nervenheilkunde 42, 430–437 (2023).
Haaf, R. et al. Wirksamkeit in Deutschland verfügbarer internetbasierter Interventionen für Depressionen – ein systematisches Assessment mit Metaanalyse. Nervenarzt 95, 206–215 (2024).
Bratan, T. et al. E-Well being in Deutschland. Entwicklungsperspektiven und internationaler Vergleich. https://www.econstor.eu/deal with/10419/251366 (2022).
Barros, P. P. et al. Assessing the Affect of Digital Transformation of Well being Providers. https://well being.ec.europa.eu/system/recordsdata/2019-11/022_digitaltransformation_en_0.pdf (2019).
Zanaboni, P. et al. Strategies to judge the consequences of internet-based digital well being interventions for residents: systematic overview of critiques. J. Med Web Res. 20, e10202 (2018).
Iribarren, S. J., Cato, Ok., Falzon, L. & Stone, P. W. What’s the financial proof for mHealth? A scientific overview of financial evaluations of mHealth options. PLoS One 12, e0170581 (2017).
Kolasa, Ok. & Kozinski, G. How one can worth digital well being interventions? A scientific literature overview. Int. J. Environ. Res. Public Well being 17, 2119 (2020).
Bates, D. W., Landman, A. & Levine, D. M. Well being apps and well being coverage: What is required? JAMA 320, 1975–1976 (2018).
Owens, D. Ok., Qaseem, A., Chou, R. & Shekelle, P. Excessive-value, cost-conscious well being care: Ideas for clinicians to judge the advantages, harms, and prices of medical interventions. Ann. Intern. Med. 154, 174–180 (2011).
Powell, A. & Torous, J. A patient-centered framework for measuring the financial worth of the scientific advantages of digital well being apps: Theoretical modeling. JMIR Ment. Well being 7, e18812 (2020).
Luo, X. et al. Price-effectiveness of cellular health-based built-in take care of atrial fibrillation: Mannequin improvement and information evaluation. J. Med. Web Res. 24, e29408 (2022).
Lewkowicz, D., Wohlbrandt, A. M. & Bottinger, E. Digital therapeutic care apps with decision-support interventions for folks with low again ache in Germany: Price-effectiveness evaluation. JMIR Mhealth Uhealth 10, e35042 (2022).
Abadie, F. & Boehler, C. Monitoring and Evaluation Framework for the European Innovation Partnership on Energetic and Wholesome Ageing (MAFEIP). https://publications.jrc.ec.europa.eu/repository/deal with/JRC96205 (2015).
Boehler, C., De Graaf, G., Steuten, L., Yang, Y. & Abadie, F. Improvement of a web-based instrument for the evaluation of well being and financial outcomes of the European innovation partnership on lively and wholesome ageing (EIP on AHA). BMC Med Inf. Decis. Mak. 15, S4 (2015).
Mukuria, C. et al. Price-effectiveness of an bettering entry to psychological therapies service. Br. J. Psychiatry 202, 220–227 (2013).
Hollinghurst, S. et al. Price-effectiveness of cognitive–behavioural remedy as an adjunct to pharmacotherapy for treatment-resistant despair in main care: Financial analysis of the CoBalT Trial. Br. J. Psychiatry 204, 69–76 (2014).
Zethraeus, N., Johannesson, M., Jönsson, B., Löthgren, M. & Tambour, M. Benefits of utilizing the net-benefit strategy for analysing uncertainty in financial analysis research. Pharmacoeconomics 21, 39–48 (2003).
Rommel, A., Bretschneider, J., Kroll, L. E., Prütz, F. & Thom, J. Inanspruchnahme psychiatrischer und psychotherapeutischer Leistungen. Individuelle Determinanten und regionale Unterschiede. J. Well being Monit. 2, 3–23 (2017).
Messner, E.-M., Probst, T., O’Rourke, T., Stoyanov, S. & Baumeister, H. mHealth functions: Potentials, limitations, present high quality and future instructions. In Digital Phenotyping and Cellular Sensing. New Developments in Psychoinformatics (eds. by Baumeister, H. & Montag, C.) (Springer Worldwide Publishing 2019), pp. 235–248.
Kolovos, S. et al. Price effectiveness of guided internet-based interventions for despair compared with management circumstances: A person-participant information meta-analysis. Depress Anxiousness 35, 209–219 (2018).
Ahlert, M., Breyer, F. & Schwettmann, L. What You Ask is What You Get: Willingness-to-Pay for a QALY in Germany. https://concepts.repec.org/p/ces/ceswps/_4239.html (2013).
Schwarzer, R. et al. Systematic overview of cost-effectiveness thresholds in ten international locations throughout 4 continents. J. Comp. Eff. Res. 4, 485–504 (2015).
IQWiG. Normal Strategies. Model 7.0. https://www.iqwig.de/en/about-us/strategies/methods-paper/ (2023).
Gensorowsky, D., Witte, J., Batram, M. & Greiner, W. Market entry and value-based pricing of digital well being functions in Germany. Price. Eff. Resour. Alloc. 20, 25 (2022).
Groene, N. & Schneck, L. Masking digital well being functions within the public insurance coverage system: How one can foster innovation in affected person care whereas mitigating monetary dangers – proof from Germany. Entrance Digital Well being 5, 1217479 (2023).
Greiner, W. & Gensorowsky, D. DiGA-Report 2022. https://www.tk.de/useful resource/blob/2125136/dd3d3dbafcfaef0984dcf8576b1d7713/tk-diga-report-2022-data.pdf (2022).
Gräfe, V., Moritz, S. & Greiner, W. Well being financial analysis of an web intervention for despair (deprexis), a randomized managed trial. Well being Econ. Rev. 10, 19 (2020).
GKV Spitzenverband. Bericht des GKV-Spitzenverbandes über die Inanspruchnahme und Entwicklung der Versorgung mit Digitalen Gesundheitsanwendungen (DiGA-Bericht). https://www.gkv-spitzenverband.de/krankenversicherung/digitalisierung/kv_diga/diga.jsp (2023).
Meskendahl, D. & Bachmann, T. Bericht des Spitzenverbands Digitale Gesundheitsversorgung über die Marktentwicklung digitaler Gesundheitsanwendungen (DiGA-Report). https://digitalversorgt.de/wp-content/uploads/2024/01/DiGA-Report-2023-SVDGV.pdf (2023).
Kessler, R. C. et al. The epidemiology of main depressive dysfunction: Outcomes from the nationwide comorbidity survey replication (NCS-R). JAMA 289, 3095–3105 (2003).
Haji Ali Afzali, H., Karnon, J. & Grey, J. A vital overview of model-based financial research of despair: modelling strategies, mannequin construction and information sources. Pharmacoeconomics 30, 461–482 (2012).
Kolovos, S. et al. Mannequin-based financial analysis of remedies for despair: A scientific literature overview. Pharmacoecon Open 1, 149–165 (2017).
Siebert, U. et al. State-transition modeling: A report of the ISPOR-SMDM modeling good analysis pactices process force-3. Worth Well being 15, 812–820 (2012).
Caro, J. J., Briggs, A. H., Siebert, U. & Kuntz, Ok. M. Modeling good analysis practices-overview: A report of the ISPOR-SMDM modeling good analysis practices process force-1. Worth Well being 15, 796–803 (2012).
Husereau, D. et al. Consolidated well being financial analysis reporting requirements (CHEERS) assertion. BMC Med. 11, 80 (2013).
Husereau, D. et al. Consolidated well being financial analysis reporting requirements 2022 (CHEERS 2022) assertion: Up to date reporting steerage for well being financial evaluations. Worth Well being 25, 3–9 (2022).
Sonnenberg, F. A. & Beck, J. R. Markov fashions in medical determination making: A sensible information. Med Decis. Mak. 13, 322–338 (1993).
Nübel, J., Müllender, S., Hapke, U. & Jacobi, F. Epidemie der Melancholy? Prävalenzentwicklung und Inanspruchnahme von Hilfs- und Versorgungsangeboten. Nervenarzt 90, 1177–1186 (2019).
Wittchen, H.-U. & Jacobi, F. Die Versorgungssituation psychischer Störungen in Deutschland. Bundesgesundheitsblatt Gesundheitsforsch Gesundheitsschutz 44, 993–1000 (2001).
Messori, A. & Trippoli, S. The outcomes of a pharmacoeconomic examine: Incremental cost-effectiveness ratio versus web financial profit. Coronary heart 103, 1746 (2017).
Krummenauer, F. & Landwehr, I. Incremental value effectiveness analysis in scientific analysis. Eur. J. Med Res. 10, 18–22 (2005).
Ulbrich, L. & Kröger, C. Financial valuation of a quality-adjusted life yr (QALY) for depressive problems amongst sufferers and non-patient respondents: A matched willingness to pay examine. Clin. Psychol. Eur 3, e3855 (2021).
Statistisches Bundesamt. Gross home product (GDP). https://www.destatis.de/EN/Themes/Financial system/Nationwide-Accounts-Home-Product/Tables/gdp-bubbles.html (2023).
Incerti, D. & Jansen, J. P. Hesim: Well being financial simulation modeling and determination evaluation. https://doi.org/10.48550/arXiv.2102.09437 (2021).
Baio, G. & Dawid, A. P. Probabilistic sensitivity evaluation in well being economics. Stat. Strategies Med. Res. 24, 615–634 (2015).
Alarid-Escudero, F. et al. An introductory tutorial on cohort state-transition fashions in R utilizing a cost-effectiveness evaluation instance. Med Decis. Mak. 43, 3–20 (2023).
Briggs, A. H., Goeree, R., Blackhouse, G. & O’Brien, B. J. Probabilistic evaluation of cost-effectiveness fashions: Selecting between therapy methods for gastroesophageal reflux illness. Med. Decis. Mak. 22, 290–308 (2002).
Hunink, M. G. M. & Weinstein, M. C. Resolution making in well being and medication. Integrating proof and values 2nd edn, Vol. 446 (Cambridge College Press, Cambridge, 2016).
Carreras, G., Baccini, M., Accetta, G. & Biggeri, A. Bayesian probabilistic sensitivity evaluation of Markov fashions for pure historical past of a illness: An software for cervical most cancers. ijph 9, 3 (2012).
Parmigiani, G. Measuring uncertainty in advanced determination evaluation fashions. Stat. Strategies Med. Res. 11, 513–537 (2002).
Kligerman, M. P., Devine, E. E., Bentzley, J. P. & Megwalu, U. C. Price-effectiveness of despair screening for otolaryngology-head and neck surgical procedure residents. Laryngoscope 131, 502–508 (2021).
Grobe, T. G. et al. Prävalenzen von Depressionen bei Erwachsenen – eine vergleichende Analyse bundesweiter Survey- und Routinedaten. Gesundheitswesen 81, 1011–1017 (2019).
Statistisches Bundesamt. Inhabitants by nationality and intercourse (quarterly figures). https://www.destatis.de/EN/Themes/Society-Setting/Inhabitants/Present-Inhabitants/Tables/liste-current-population.html#616588 (2023).
Stahmeyer, J. T. et al. The state of take care of individuals with a prognosis of despair. Dtsch Arztebl Int 119, 458–465 (2022).
Gräfe, Ok., Zipfel, S., Herzog, W. & Löwe, B. Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)”. Diagnostica 50, 171–181 (2004).
Kroenke, Ok., Spitzer, R. L. & Williams, J. B. The PHQ-9: Validity of a short despair severity measure. J. Gen. Intern Med. 16, 606–613 (2001).
Zuithoff, N. P. A. et al. The affected person well being questionnaire-9 for detection of main depressive dysfunction in main care: Penalties of present thresholds in a crosssectional examine. BMC Fam. Pr. 11, 98 (2010).
Bundesärztekammer, Kassenärztliche Bundesvereinigung & Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale VersorgungsLeitlinie Unipolare Melancholy. Langfassung, Model 3.1. https://register.awmf.org/de/leitlinien/element/nvl-005 (2022).
Whisman, M. A. & Richardson, E. D. Normative information on the beck despair inventory-second version (BDI-II) in school college students. J. Clin. Psychol. 71, 898–907 (2015).
Kocalevent, R.-D., Hinz, A. & Brähler, E. Standardization of the despair screener affected person well being questionnaire (PHQ-9) within the basic inhabitants. Gen. Hosp. Psychiatry 35, 551–555 (2013).
Statistisches Bundesamt. Krankheitskosten: Deutschland, Jahre, Krankheitsdiagnosen (ICD-10), Geschlecht, Altersgruppen. https://www-genesis.destatis.de/genesis/on-line?sequenz=tabelleErgebnis&selectionname=23631-0003&sachmerkmal=ICD10Y&sachschluessel=ICD10-F32-F34&transponieren=true#abreadcrumb (2023).
Sonntag, M., König, H.-H. & Konnopka, A. The estimation of utility weights in cost-utility evaluation for psychological problems: A scientific overview. Pharmacoeconomics 31, 1131–1154 (2013).
Whitehead, S. J. & Ali, S. Well being outcomes in financial analysis: The QALY and utilities. Br. Med Bull. 96, 5–21 (2010).
Deutsche Bundesbank. Low cost Curiosity Charges. https://www.bundesbank.de/en/statistics/money-and-capital-markets/interest-rates-and-yields/discount-interest-rates/discount-interest-rates-793422 (2023).
Statistisches Bundesamt. Bevölkerung Nach Altersgruppen (ab 2011). https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Bevoelkerung/Bevoelkerungsstand/Tabellen/liste-altersgruppen.html#474508 (2023).
Statistisches Bundesamt. Sterbefälle – Fallzahlen nach Tagen, Wochen, Monaten, Altersgruppen, Geschlecht und Bundesländern für Deutschland 2016-2023. https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Bevoelkerung/Sterbefaelle-Lebenserwartung/Tabellen/sonderauswertung-sterbefaelle.html (2023).
Meyer, B. et al. Results of an Web intervention (Deprexis) on extreme despair signs: Randomized managed trial. Web Interventions 2, 48–59 (2015).
Moritz, S., Schilling, L., Hauschildt, M., Schröder, J. & Treszl, A. A randomized managed trial of internet-based remedy in despair. Behav. Res. Ther. 50, 513–521 (2012).
Moritz, S. et al. Results of on-line intervention for despair on temper and constructive signs in schizophrenia. Schizophr. Res. 175, 216–222 (2016).
Beiwinkel, T., Eißing, T., Telle, N.-T., Siegmund-Schultze, E. & Rössler, W. Effectiveness of a web-based intervention in lowering despair and illness absence: Randomized managed trial. J. Med. Web Res. 19, e213 (2017).
Baumeister, A. & Moritz, S. Studienbericht Novego Melancholy. https://www.novego.de/wp-content/uploads/2023/10/20230907_Studienbericht-Novego-Melancholy-final.pdf (2023).
Bundesinstitut für Arzneimittel und Medizinprodukte. Arzneimittel-Festbeträge. https://www.bfarm.de/DE/Arzneimittel/Arzneimittelinformationen/Festbetraege-und-Zuzahlungen/Festbetraege/_node.html (2023).
Wissenschaftliches Institut der AOK. PharMaAnalyst. Verordnungsdaten 2022. https://arzneimittel.wido.de/PharMaAnalyst/?1 (2022).
IGES Institut. Arzneimittelatlas: Die bedeutendsten Mittel mit stimulierender Wirkung auf das Zentralnervensystem (Psychoanaleptika). N06 Psychoanaleptika. https://www.arzneimittel-atlas.de/arzneimittel/n06-psychoanaleptika/top-10/ (2022).
Kassenärztliche Bundesvereinigung. Einheitlicher Bewertungsmaßstab (EBM). https://www.kbv.de/html/ebm.php (2023).
GKV Spitzenverband. Psych-Entgeltsystem. PEPP 2023. https://www.gkv-spitzenverband.de/krankenversicherung/krankenhaeuser/psychiatrie/pepp_entgeltsystem_2023/pepp_5.jsp (2023).
Statista. Durchschnittliche Verweildauer in deutschen Krankenhäusern nach medizinischer Fachabteilung im Jahr 2021. https://de.statista.com/statistik/daten/studie/369355/umfrage/verweildauer-in-deutschen-krankenhaeusern-nach-medizinischen-fachabteilungen/ (2021).
Osterloh, F. Psychische Erkrankungen: Hohe Rehospitalisierungsrate. Aerzteblatt 10, 347–348 (2011).
Mohiuddin, S. & Payne, Ok. Utility values for adults with unipolar despair: Systematic overview and meta-analysis. Med. Decis. Mak. 34, 666–685 (2014).
Kolovos, S. et al. Utility scores for various well being states associated to despair: Particular person participant information evaluation. Qual. Life Res. 26, 1649–1658 (2017).
Revicki, D. A. & Wooden, M. Affected person-assigned well being state utilities for depression-related outcomes: Variations by despair severity and antidepressant medicines. J. Have an effect on Disord. 48, 25–36 (1998).
